Thousands join sarcoidosis registry to map disease journey
NCT ID NCT06234384
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This registry study aims to collect information from over 6,800 people with sarcoidosis about their symptoms, diagnosis, treatments, and daily life. Participants complete surveys and can share their electronic health records. The goal is to create a detailed picture of sarcoidosis over time to help researchers better understand the disease and improve care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help researchers better understand sarcoidosis and identify unmet needs, potentially guiding future treatments.
- What could go wrong
- This is an observational registry, not a treatment trial. It will not directly test any therapy, and results depend on patient participation and data quality.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Foundation For Sarcoidosis Research
RECRUITINGChicago, Illinois, 60654, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scans may unlock hidden risks in minority communities
- Can immune profiling unlock the hidden stages of tuberculosis?
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- Home devices may spot lung flare-ups before they become emergencies
- Massive study tracks lung disease progression in 4,000 patients
- 5,000 patients to help unlock secrets of inflammatory heart disease